LumiraDx Ltd
NASDAQ:LMDX

Watchlist Manager
LumiraDx Ltd Logo
LumiraDx Ltd
NASDAQ:LMDX
Watchlist
Price: 0.016 USD Market Closed
Updated: May 19, 2024

LumiraDx Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LumiraDx Ltd
Income from Continuing Operations Peer Comparison

Comparables:
SN
LIVN
EKF
AGL
CREO

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
LumiraDx Ltd
NASDAQ:LMDX
Income from Continuing Operations
-$447.6m
CAGR 3-Years
-50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Income from Continuing Operations
$263m
CAGR 3-Years
-16%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Income from Continuing Operations
-$31.7m
CAGR 3-Years
58%
CAGR 5-Years
32%
CAGR 10-Years
N/A
EKF Diagnostics Holdings PLC
LSE:EKF
Income from Continuing Operations
£2.7m
CAGR 3-Years
-38%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Angle PLC
LSE:AGL
Income from Continuing Operations
-£22.3m
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
Income from Continuing Operations
-£26.9m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is LumiraDx Ltd's Income from Continuing Operations?
Income from Continuing Operations
-447.6m USD

Based on the financial report for Dec 31, 2022, LumiraDx Ltd's Income from Continuing Operations amounts to -447.6m USD.

What is LumiraDx Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-50%

Over the last year, the Income from Continuing Operations growth was -344%. The average annual Income from Continuing Operations growth rates for LumiraDx Ltd have been -50% over the past three years .